• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同步放化疗在头颈部癌患者中的作用:综述

The role of concurrent chemo-radiotherapy in patients with head and neck cancers: a review.

作者信息

Al-Sarraf M D

机构信息

Williams Beaumont Hospital, Royal Oak, Michigan, USA.

出版信息

Gulf J Oncolog. 2007 Jul(2):8-16.

PMID:20084719
Abstract

Concurrent chemo-radiotherapy has become the standard treatment for patients with locally advanced head and neck cancers. In surgically operated patients post-operative concurrent chemo-radiotherapy is the standard of care. For organ/speech preservation and in patients who are not surgically operable the standard of care is concurrent chemo-radiotherapy. In patients with locally advanced NPC although concurrent chemo-radiotherapy was superior to RT only, the standard of care is concurrent chemo-radiotherapy followed by three courses of adjuvant combination chemotherapy. Single daily fraction irradiation is the standard of care when given concomitant with chemotherapy. Although, single agent cisplatin given on every three weeks schedule is the standard of care, this could be replaced safely and as effectively with weekly carboplatin given with RT with much less side effects and with similar efficacy.

摘要

同步放化疗已成为局部晚期头颈癌患者的标准治疗方法。对于接受手术治疗的患者,术后同步放化疗是标准的治疗方案。对于器官/言语保留以及无法进行手术的患者,标准治疗方案是同步放化疗。在局部晚期鼻咽癌患者中,尽管同步放化疗优于单纯放疗,但标准治疗方案是同步放化疗后进行三个疗程的辅助联合化疗。与化疗同时进行时,每日单次分割照射是标准的治疗方案。虽然每三周一次的顺铂单药治疗是标准的治疗方案,但可以安全有效地用每周一次的卡铂与放疗联合使用来替代,副作用小得多且疗效相似。

相似文献

1
The role of concurrent chemo-radiotherapy in patients with head and neck cancers: a review.同步放化疗在头颈部癌患者中的作用:综述
Gulf J Oncolog. 2007 Jul(2):8-16.
2
Feasibility and pharmacokinetics of paclitaxel, carboplatin, and concurrent radiotherapy for regionally advanced squamous cell carcinoma of the head and neck and for regionally advanced non-small cell lung cancer.紫杉醇、卡铂及同步放疗用于局部晚期头颈部鳞状细胞癌和局部晚期非小细胞肺癌的可行性及药代动力学
Semin Oncol. 1995 Oct;22(5 Suppl 12):17-21.
3
The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).对头颈部晚期局部区域鳞状细胞癌(SCCHN)患者同步接受每周一次卡铂、紫杉醇和每日放疗(RT)时使用氨磷汀进行黏膜保护的评估。
Semin Oncol. 2004 Dec;31(6 Suppl 18):2-7. doi: 10.1053/j.seminoncol.2005.02.001.
4
The role of induction chemotherapy in the treatment of patients with locally advanced head and neck cancers: A review.诱导化疗在局部晚期头颈癌患者治疗中的作用:综述
Gulf J Oncolog. 2008 Jul(4):8-18.
5
Chemoradiotherapy for the treatment of regionally advanced head and neck cancers.
Semin Oncol. 1994 Oct;21(5 Suppl 12):35-44.
6
Evidence-based radiation oncology in head and neck squamous cell carcinoma.头颈部鳞状细胞癌的循证放射肿瘤学
Radiother Oncol. 2007 Oct;85(1):156-70. doi: 10.1016/j.radonc.2007.04.002. Epub 2007 May 4.
7
Concomitant weekly cisplatin and altered fractionation radiotherapy in locally advanced head and neck cancer.同期每周顺铂和改变分割放疗局部晚期头颈部癌症。
Cancer. 2010 Oct 1;116(19):4533-40. doi: 10.1002/cncr.25189.
8
[Adjuvant treatment of head and neck cancers: advances and challenges].[头颈部癌症的辅助治疗:进展与挑战]
Bull Cancer. 2007 Sep;94(9):823-7.
9
Concomitant boost radiotherapy with concurrent weekly cisplatin in advanced head and neck cancers: a phase II trial.晚期头颈癌同步推量放疗联合每周顺铂同步化疗:一项II期试验
Radiother Oncol. 2005 May;75(2):186-92. doi: 10.1016/j.radonc.2004.12.004. Epub 2004 Dec 23.
10
[Combined radiotherapy with cis- or carboplatin in advanced head and neck tumors].[晚期头颈部肿瘤中顺铂或卡铂与放疗联合应用]
Strahlenther Onkol. 1989 Sep;165(9):647-51.

引用本文的文献

1
CircPUM1 Knockdown Confers Radiosensitivity in Oral Squamous Cell Carcinoma by Regulating the miR-580/STAT3 Pathway.环状PUM1基因敲低通过调控miR-580/STAT3信号通路赋予口腔鳞状细胞癌放射敏感性
Front Genet. 2022 Aug 25;13:907219. doi: 10.3389/fgene.2022.907219. eCollection 2022.
2
Cellular uptake and cytoplasm / DNA distribution of cisplatin and oxaliplatin and their liposomal formulation in human colorectal cancer cell HCT116.顺铂和奥沙利铂及其脂质体剂型在人结直肠癌细胞 HCT116 中的细胞摄取和细胞质/DNA 分布。
Invest New Drugs. 2011 Dec;29(6):1321-7. doi: 10.1007/s10637-010-9494-3. Epub 2010 Jul 24.